Virtu Financial’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Virtu Financial’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,674	Closed	-$20K	–	2426
2023 Q1	$20K	Buy	+11,674	New	+$26.5K	﹤0.01%	1249
2022 Q3	–	Sell	-218	Closed	-$3K	–	2502
2022 Q2	$3K	Buy	+218	New	+$3.18K	﹤0.01%	1490
2022 Q1	–	Sell	-3,477	Closed	-$66K	–	2390
2021 Q4	$66K	Buy	3,477 +2,602	+297%	+$73.8K	0.01%	1263
2021 Q3	$40K	Sell	875 -443	-34%	-$21.7K	﹤0.01%	1306
2021 Q2	$80K	Buy	+1,318	New	+$92.6K	0.01%	1251
2020 Q4	–	Sell	-218	Closed	-$11K	–	1920
2020 Q3	$11K	Buy	+218	New	+$17.6K	﹤0.01%	954
2019 Q4	$27K	Sell	106 -62	-37%	-$12.1K	﹤0.01%	1283
2019 Q3	$34K	Sell	168 -62	-27%	-$14.9K	﹤0.01%	1244
2019 Q2	$82K	Buy	230 +227	+7,567%	+$177K	﹤0.01%	1164
2019 Q1	$4K	Sell	3 -4	-57%	-$6.49K	﹤0.01%	1361
2018 Q4	$11K	Hold	7	–	–	﹤0.01%	1436
2018 Q3	$21K	Sell	7 -32	-82%	-$92.5K	﹤0.01%	1404
2018 Q2	$128K	Buy	39 +11	+39%	+$37.1K	0.01%	1609
2018 Q1	$99K	Buy	+28	New	+$83K	0.01%	1580
2017 Q4	–	Sell	-10	Closed	-$43K	–	3193
2017 Q3	$43K	Buy	+10	New	+$51.4K	﹤0.01%	2245

Other funds holding TMBR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CPG

Cornerstone Planning Group Fairfield, New Jersey $749M AUM 17.97% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Virtu Financial's TMBR Position: Q2 2023 in Review

Virtu Financial sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q2 2023, closing a stake of 11,674 shares — an estimated $20K sold.

Virtu Financial first reported a position in TMBR in Q3 2017 and held it in 15 quarters. The position peaked at $128K in Q2 2018. 9 funds tracked by Wall St. Rank hold TMBR as of Q2 2023.

Virtu Financial reported no remaining Timber Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Virtu Financial sold 11,674 Timber Pharmaceuticals, Inc. shares in Q2 2023, an estimated $20K.
Virtu Financial first reported a position in Timber Pharmaceuticals, Inc. in Q3 2017 and held it in 15 quarters.
Virtu Financial's Timber Pharmaceuticals, Inc. position peaked at $128K in Q2 2018.
9 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.